Filing Details
- Accession Number:
- 0001562180-21-005999
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-09-17 16:27:21
- Reporting Period:
- 2021-09-15
- Accepted Time:
- 2021-09-17 16:27:21
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1770121 | Sana Biotechnology Inc. | SANA | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1616640 | Sunil Agarwal | C/O Sana Biotechnology, Inc. 188 East Blaine Street, Suite 400 Seattle WA 98102 | Evp, Head Of Development & Cmo | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2021-09-15 | 58,373 | $26.07 | 1,551,627 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-09-16 | 1,627 | $26.00 | 1,550,000 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 5, 2021.
- The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $26.00 to $26.225, inclusive. The reporting person undertakes to provide to Sana Biotechnology, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.
Billionaire Hedge Funds
